TTYH3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.943000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.632800E-01
Normal-vs-Stage2
5.554200E-01
Normal-vs-Stage3
8.759600E-01
Normal-vs-Stage4
5.789200E-01
Stage1-vs-Stage2
8.324400E-02
Stage1-vs-Stage3
5.864200E-01
Stage1-vs-Stage4
1.283580E-01
Stage2-vs-Stage3
7.462600E-01
Stage2-vs-Stage4
8.800000E-01
Stage3-vs-Stage4
9.249600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.769800E-01
Normal-vs-AfricanAmerican
5.592800E-01
Normal-vs-Asian
2.163600E-01
Caucasian-vs-AfricanAmerican
6.127200E-01
Caucasian-vs-Asian
3.515000E-03
AfricanAmerican-vs-Asian
2.738200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.504600E-01
Normal-vs-Female
6.352400E-01
Male-vs-Female
4.197600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.067400E-01
Normal-vs-Age(41-60Yrs)
5.443200E-01
Normal-vs-Age(61-80Yrs)
7.309600E-01
Normal-vs-Age(81-100Yrs)
7.884400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.270400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.195800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.975600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.106800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.453800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.498800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.659200E-01
Normal-vs-Daily Drinker
9.122600E-01
Normal-vs-Weekly Drinker
2.945400E-01
Normal-vs-Occasional Drinker
7.784200E-01
Normal-vs-Social Drinker
6.698600E-01
Non Drinker-vs-Daily Drinker
7.226400E-01
Non Drinker-vs-Weekly Drinker
7.323700E-02
Non Drinker-vs-Occasional Drinker
9.330600E-01
Non Drinker-vs-Social Drinker
6.903800E-01
Daily Drinker-vs-Weekly Drinker
6.555900E-02
Daily Drinker-vs-Occasional Drinker
7.178400E-01
Daily Drinker-vs-Social Drinker
5.308000E-01
Weekly Drinker-vs-Occasional Drinker
1.643790E-01
Weekly Drinker-vs-Social Drinker
2.707000E-01
Occasional Drinker-vs-Social Drinker
7.967400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.521600E-01
Normal-vs-Grade 2
9.655400E-01
Normal-vs-Grade 3
9.756400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.402200E-02
Grade 1-vs-Grade 3
5.589800E-02
Grade 1-vs-Grade 4
5.521600E-01
Grade 2-vs-Grade 3
8.384800E-01
Grade 2-vs-Grade 4
9.655400E-01
Grade 3-vs-Grade 4
9.756400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.681000E-01
Normal-vs-NonDiabetic
5.981000E-01
Diabetic-vs-NonDiabetic
2.140200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.375000E-01
Normal-vs-NoPancreatitis
6.848200E-01
Pancreatitis-vs-NoPancreatitis
3.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.797800E-01
Normal-vs-N1
5.662000E-01
N0-vs-N1
1.670060E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.311800E-01
Normal-vs-TP53-NonMutant
6.470400E-01
TP53-Mutant-vs-TP53-NonMutant
3.777900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
